Form 4: Director Ravit Barniv Exercises Ormat RSU Grant

Sentiment:

Statement of Changes in Beneficial Ownership


Ormat Technologies director Ravit Barniv acquired 1,766 shares of common stock following the vesting of restricted stock units.

Summary

  • Director Ravit Barniv acquired 1,766 shares of Ormat Technologies (ORA) common stock.
  • The acquisition resulted from the vesting of 1,766 restricted stock units (RSUs).
  • The transaction occurred on May 7, 2026, representing the first-year anniversary of the original grant.
  • The shares were acquired at a price of $0 per share upon vesting.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative event reflecting standard director compensation rather than a strategic market signal.

Positives

  • Director maintains a direct equity stake of 1,766 shares in the company.

Negatives

  • None.

Risks

  • None.

Future Outlook

Not applicable.

Industry Context

StockSavvy.ai notes that this is a routine disclosure of equity compensation vesting for a corporate director, which is standard practice in the renewable energy and geothermal sector.

Comparison to Industry Standards

  • The transaction follows standard corporate governance practices regarding director compensation and equity vesting schedules.

Stakeholder Impact

  • Minimal impact on shareholders as this represents standard equity compensation.

Next Steps

  • None.

Key Dates

DateDescription
05/07/2026Vesting date of RSUs and acquisition of common stock.
05/11/2026Date of filing.

Keywords

Ormat Technologies, ORA, Form 4, Insider Trading, Restricted Stock Units, Director Ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.